Denali Therapeutics Inc.
← Back to DNLI Overview

Denali Therapeutics Inc. (DNLI)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-6.96

Financial Fundamentals

DNLIQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2016-03-31-1.59
2016-06-30-1.59
2016-09-30-1.19
2016-12-31-2.49
2017-03-31-2.27
2017-06-30-16.76
2017-09-30-19.86
2017-12-31-5.28
2018-03-31-18.93
2018-06-30-6.46
2018-09-30-14.18
2018-12-316.30
2019-03-31-14.71
2019-06-30-8.53
2019-09-30-7.98
2019-12-31-7.64
2020-03-31-7.96
2020-06-30-10.79
2020-09-30-16.59
2020-12-3110.26
2021-03-31-24.61
2021-06-30-39.22
2021-09-30-18.28
2021-12-31-17.98
2022-03-31-15.47
2022-06-30-15.33
2022-09-30-9.13
2022-12-31-9.40
2023-03-31-7.20
2023-06-305.51
2023-09-30-7.16
2023-12-31-6.24
2024-03-31-7.56
2024-06-30-9.33
2024-09-30-11.56
2024-12-31-7.60
2025-03-31-4.36
2025-06-30-4.86
2025-09-30-4.91
2025-12-31-5.65
2026-03-31-6.96

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.